Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page
- Check3 days agoChange DetectedNew version 54 dated 2026-08-06 introduces an updated Study Status and Revision: v3.6.5; the previous v3.6.4 entry from 2026-05-13 is removed from the history.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page shows a revision update from v3.6.3 to v3.6.4, indicating a new version of the page. This update reflects an underlying software revision rather than a change to the study details displayed.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedA new revision entry v3.6.3 was added to the record history, superseding the previous v3.6.2 and signaling an updated version of the study record.SummaryDifference0.1%

- Check46 days agoChange DetectedThe revision label on the page updated from v3.6.0 to v3.6.2, representing a minor version update to the interface; no study content or important functionality changes are indicated.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded recruitment status No longer looking for participants and a new revision tag v3.6.0. The earlier revision v3.5.5 was removed from the history.SummaryDifference0.2%

- Check68 days agoChange DetectedThe history now shows a new latest revision labeled v3.5.5, with the previous v3.5.4 removed from the record. This update changes the page's revision metadata rather than the study content or results.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.